Karen Slabas, MD
Obstetrics & Gynecology · Rockwall, TXNPI 1629370705
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (55.7%), food and beverage and education — rather than concentrated in one kind of arrangement. Integra Lifesciences Corporation accounts for 62.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $3,866 and has fallen 80.1% since, to $769 in 2025.
Across 76 payments — averaging $74.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$3K
- Astellas Pharma US Inc$657
- Organon$169
- Olympus America Inc.$168
- Mayne Pharma Commercial LLC$150
- Axonics, Inc.$126
- plus $859 from 21 others
What the payments were for
- Food & beverage$2,30541%
- Education$1853%
- Other$3,13756%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 7 | $3,499 |
| Astellas Pharma US Inc | 14 | $657 |
| Organon | 6 | $169 |
| Olympus America Inc. | 1 | $168 |
| Mayne Pharma Commercial LLC | 3 | $150 |
| Axonics, Inc. | 7 | $126 |
| Abiomed | 1 | $121 |
| Hologic Sales And Service, LLC | 3 | $107 |
| AbbVie(2 entities) | 6 | $95 |
| Millicent US Inc | 4 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Boston Scientific | 2 | $46 |
| Vertical Pharmaceuticals, LLC | 2 | $42 |
| Exeltis, USA Inc. | 2 | $36 |
| Johnson & Johnson | 1 | $33 |
| Pfizer | 1 | $33 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Meditrina | 2 | $27 |
| Mimedx Group, Inc. | 1 | $25 |
| Vertex | 1 | $23 |
| Merck | 1 | $21 |
| Smith+Nephew | 1 | $20 |
| Coopersurgical, Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $16 |
| Avion Pharmaceuticals | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Minerva Surgical, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$3,949
- Veozah$356
- INTEGRA DERMAL REGENERATION TEMPLATE$271
- PRIMATRIX$271
- ANNOVERA$109
How this compares
$5,627 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 38 | $2,614 |
| ProgesteroneProgesterone, Micronized | 30 | $2,404 |
| Halobetasol Propionate | 13 | $441 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Rockwall
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.